ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,200.00
0.41%
Dow Jones
38,711.29
0.36%
Brent Oil
77.46
0.45%
Bitcoin
70,917.06
0.50%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Centogene NV (CNTG) Quote

Centogene NV

Centogene NV (CNTG)

NASDAQ
0.3644
-0.0214
(-5.55%)
Closed June 04 4:00PM
Delayed by 15 minutes
0.3786
0.0142
(3.90%)
After Hours: 7:17PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.3786
Bid
0.365
Ask
0.38
Volume
46,688
0.3613 Day's Range 0.3899
0.3457 52 Week Range 1.98
Market Cap
9.936M
Previous Close
0.3858
Open
0.371
Last Trade
18
@
0.38
Last Trade Time
Financial Volume
$ 17,232
VWAP
0.369098
Average Volume (3m)
174,496
Shares Outstanding
27,600,000
Dividend Yield
-
PE Ratio
-0.31
Earnings Per Share (EPS)
-1.15
Revenue
66.93M
Net Profit
-31.84M

About Centogene NV

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a... Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.centogene.com
Headquarters
Rostock, Deu
Founded
1970
Centogene NV is listed in the Medical Laboratories sector of the NASDAQ with ticker CNTG. The last closing price for Centogene NV was $0.39. Over the last year, Centogene NV shares have traded in a share price range of $ 0.3457 to $ 1.98.

Centogene NV currently has 27,600,000 shares outstanding. The market capitalization of Centogene NV is $9.94 million. Centogene NV has a price to earnings ratio (PE ratio) of -0.31.

CNTG Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 31 2024
Edgar (US Regulatory)

CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in...

May 31 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 29 2024
Edgar (US Regulatory)

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

May 17 2024
Edgar (US Regulatory)

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company...

May 15 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 15 2024
Edgar (US Regulatory)

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...

May 15 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 15 2024
Edgar (US Regulatory)

CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead...

May 14 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0114-2.923076923080.390.40.351782480.38182868CS
4-0.0624-14.14965986390.4410.55440.34573637920.38946201CS
12-0.3184-45.6814921090.6970.750.34571744960.45822008CS
26-0.8414-68.96721311481.221.280.3457915700.52140615CS
52-0.5324-58.4412733260.9111.980.34573264751.25159359CS
156-9.3614-96.1129363459.7411.950.34572059741.78185445CS
260-13.7214-97.31489361714.1360.34571624263.64966761CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
$ 11.98
(667.95%)
185.79M
VSTEVast Renewable Ltd
$ 4.49
(79.60%)
9.96M
SOBRSOBR Safe Inc
$ 0.4507
(71.04%)
268.05M
MFImF International Ltd
$ 1.315
(41.40%)
2.02M
DHACUDigital Health Acquisition Corporation
$ 23.06
(40.61%)
3.95k
JDZGJIADE Ltd
$ 1.72
(-86.21%)
14.66M
NDRAENDRA Life Sciences Inc
$ 0.086
(-60.37%)
72.34M
ALBTAvalon GloboCare Corporation
$ 0.85
(-30.89%)
5.97M
EQEquillium Inc
$ 1.05
(-28.57%)
10.83M
ATGLAlpha Technology Group Limited
$ 2.86
(-28.32%)
103.33k
SOBRSOBR Safe Inc
$ 0.4507
(71.04%)
268.05M
MLGOMicroAlgo Inc
$ 11.98
(667.95%)
185.79M
SQQQProShares UltraPro Short QQQ
$ 9.86
(-0.70%)
125.61M
FFIEFaraday Future Intelligent Electric Inc
$ 0.557
(-10.85%)
101.59M
CRKNCrown Electrokinetics Corporation
$ 0.1044
(-11.45%)
92.21M

CNTG Discussion

View Posts
Termite7 Termite7 2 weeks ago
Good news!!!
👍️0
Awl416 Awl416 3 weeks ago
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
👍️0
LessIsMore LessIsMore 10 months ago
CNTG built a position in this stock over the last several weeks. Seems like there's lots to like EXCEPT for the fact that we have a low volume stock with an anxious seller.
👍️0
Invest-in-America Invest-in-America 11 months ago
CNTG: More news; this could run.

https://www.prnewswire.com/news-releases/lifera-and-centogene-enter-strategic-collaboration--forming-saudi-arabian-joint-venture-to-increase-access-to-leading-data-driven-multiomic-testing-301866231.html#:~:text=Lifera%20and%20CENTOGENE%2C%20Enter%20Strategic,Leading%20Data%2DDriven%20Multiomic%20Testing
👍️0
Triple nickle Triple nickle 11 months ago
Iffy right here
👍️0
Invest-in-America Invest-in-America 11 months ago
CNTG: See the NEW 'Chart' on this, below!!!!

👍️0
Invest-in-America Invest-in-America 11 months ago
CNTG: Here's that news!!! (See below!!!)

👍️0
TheFinalCD TheFinalCD 11 months ago
CNTG NEWS https://finance.yahoo.com/news/centogene-lifera-biopharma-company-owned-113000204.html

https://finviz.com/quote.ashx?t=CNTG&ty=c&ta=1&p=d


CENTOGENE will receive a $30 million investment in the form of a mandatory convertible loan with a six-month term and a conversion price of $2.20 per share of CENTOGENE’s common stock, as well as significant JV performance-related milestone payments and revenue-based royalties until the year 2033
👍️0
Jess070283 Jess070283 1 year ago
Warming up After Hours…
👍️0
TheFinalCD TheFinalCD 1 year ago
CONGRAT$
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: I gots tah PASS on this creepy stock!!! My E-Turd could not even do the MATH!!! (I'll get suckered!!) CONGRATS TO THOSE WHO ALREADY SCORED!!!
👍️0
gozz1254 gozz1254 1 year ago
Halted again eom
👍️0
Jess070283 Jess070283 1 year ago
Ok the dip has ripped.!$$$$
👍️0
Jess070283 Jess070283 1 year ago
Loading this dip for the rip…
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: Ooooops!!! And here we go, AGAIN!!
👍️0
catty catty 1 year ago
makinezmoney: thanks, but I 'm not king on any new posiitions
👍️0
makinezmoney makinezmoney 1 year ago
$CNTG: BIggggggg spike here at 0.94

Awaken the KRAKEN !!!!!!!!!


Lets see whats about to go down here.......................

https://www.centogene.com/

https://finance.yahoo.com/news/centogene-reaches-12-500-patient-120000034.html


GO $CNTG
👍️0
catty catty 4 years ago
since test is available on AMZN in Germany, hopefully it'll be approved to be sold by them in the USA
👍️0
catty catty 4 years ago
Fox Business covered CNTG this morning. Just took a small position. Intend to be out of most of my stocks before election, except for the COVID-19 ones, including ZM
👍️0
Timetravelerdos Timetravelerdos 4 years ago
CENTOGENE Announces Convenient At-Home Coronavirus Test Solution Now Available in Germany on Online Marketplace!

CENTOGENE announces test kits for the detection of SARS-CoV-2 virus RNA now available on Amazon in Germany - the first of its type offered on the online marketplace
Offering includes delivery of a full, safe, and high-quality COVID-19 testing solution - significantly broadening access to the Company's innovative tests
Short process times and digital transmission of reports deliver results directly to the customer
Tests validated on the basis of the World Health Organization's (WHO)/Charite's reference guidelines

https://finance.yahoo.com/news/centogene-announces-convenient-home-coronavirus-063000951.html

👍️0
rstar rstar 4 years ago
right? and already doing rapid testing for lufthansa at frankfurt airport- and FDA EUA approved and partnered for school testing in US.

surprised not moving back to highs yet...
👍️0
Timetravelerdos Timetravelerdos 4 years ago
AT Home Testing...No Brainer This is Huge !!! Go CNTG ! Approved by World Health Organization !!
👍️0
rstar rstar 4 years ago
at home testing through amazon in germany~ boom! 14.30

i see new highs coming soon

$CNTG!
👍️0

Your Recent History

NASDAQ
CNTG
Centogene NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved